๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Later development of asthma in patients with a negative methacholine inhalation challenge examined for suspected asthma

โœ Scribed by Hannu Puolijoki; Olli Impivaara; Kari Liippo; Eero Tala


Publisher
Springer
Year
1992
Tongue
English
Weight
370 KB
Volume
170
Category
Article
ISSN
0341-2040

No coin nor oath required. For personal study only.

โœฆ Synopsis


A negative methacholine inhalation challenge (MIC) in a patient with suspected bronchial asthma is generally considered to make this diagnosis unlikely. Nevertheless, the patient may later develop asthma. To estimate the proportion that eventually becomes asthmatic, a 10 year follow-up study was carried out on 334 consecutive MIC-negative patients aged 14-80 years. The development of asthma among these patients was assessed on the basis of entitlement to preferential refund from the cost of antiasthmatic therapy granted for them under national health insurance. During the follow-up 30 patients (9%) were granted the refund. There was no significant difference between men and women in this respect. Patients who developed asthma were somewhat older than those who did not. A family history of allergy, allergic rhinitis, and positive reactions to skin prick tests were significantly more common in patients with future asthma. These patients also had a lower mean forced expiratory volume in 1 sec (FEV1) (% of predicted) and a higher mean increase in PEF after an inhaled sympathomimetic than those remaining free from asthma. In multivariate analyses with a logistic model, 3 risk indicators proved independent predictors of future asthma: age, positive family history of allergy, and FEVI (% of predicted).


๐Ÿ“œ SIMILAR VOLUMES


Repeatability of methacholine challenges
โœ Bent Klug; Hans Bisgaard ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 126 KB ๐Ÿ‘ 2 views

To determine the repeatability of bronchial responsiveness in awake young children, two methacholine challenge tests were performed on separate days in 16 children with stable asthma (mean age, 3 3/4 years). Methacholine was administered using a new method for quantitative delivery of aerosol that e